FDA Investigator Yen Tso Kuo
Yen Tso Kuo has conducted inspections on 75 sites in 1 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
75
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yen Tso Kuo:
Aimee K Contreras,
Alex G Kalugin,
Alexandra B Pitkin,
Alexandra M Cossi,
Ali Hernandez,
Amanda N Schaupp,
Andrew B Slarve,
Angel K Sandhu,
Angela Shepas,
Angelica Ornelas,
Anna L Marroquin,
Anna L Viveros Hernandez,
Ashar P Parikh,
Bonnie I Needleman,
Breena L D'ambrogi,
Brian R Henderson,
Brian Ravitch,
Bruce D Broidy,
Bruce R Burrell,
Burnsb,
Carey A Watson,
Carl Lee,
Carrie E Thrasher,
Cathleen A Carr Sharpe,
Cathryn M Groehnert,
CDR Rochelle B Young, RPh, MSA,
Celena Ngo,
Chloe Anne Leong,
Christine M Parmentier,
Christopher D Washington,
Christopher J Lee,
Christopher M Jenner,
Cindy W Lewis,
Courtney R Bolton,
Cristina Resendiz Navarrete,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Darrin E Davis,
David G Eng,
David G Whitman,
David Y Hernandez,
Davis,
Deborah W Hsu,
Debra J Fracassa,
Doan T Nguyen, PharmD,
Edna J Hidalgo,
Eileen T Dupont,
Elaine S Chow,
Elizabeth C Ajuzie,
Elodie X Tong Lin,
Emal Wahab,
Eric W Anderson,
Estefania Fernandez,
Frank P Bianco,
Gabriel Craig,
Garrad R Poole,
Geoffrey M Leist,
Grace P Santos,
Greg K Keshishyan,
Gulshan R Anand,
Gunneet Kaur,
Helen J Hamaoka,
Henry E Carrillo,
Herminio C Francisco,
Hunter M Vice,
Ingrid A Zambrana,
Irma D Padilla,
Jacqueline O Snell,
James A Barreto,
James P Stallings,
Jane G Choi,
Janice M Loy,
Janice Wai,
Jazmine M Welcher,
Jeff M Uriarte,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Joanne M Fukuda,
Joey V Quitania,
John A Liu,
Jonathan K Dare,
Jorge L Bertran,
Joseph C Yen,
Joseph H Lam,
Joseph Tibay,
Juan A Morales,
Judy C Nepsa,
Julia Ventura,
Ka L Wong,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karla J Gibler,
Kelley,
Kelvin X Sanders,
Kevin Lee,
Kevin T Gerrity,
Kimberly M Lichter,
Kimiko G Casuga,
Kristin M Abaonza,
Larkin R Buckalew,
Leonard H Lavi,
Lija V Fellows,
Lilly O Barton,
Liming Zhang,
Linda S Shook,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lydia S Chan,
Mabel M Lee,
Marco A Solorio,
Margo C Jones,
Maridali Deleon Torres,
Mark Gray,
Mark I Nakano,
Mary C Acton,
Mary C Wall,
Matthew A Walburger,
Matthew J Johnson,
Maxyne T Lam,
Mcgrewp,
Megan E Kulas,
Michael D Garcia,
Michael S Araneta,
Michael S Call,
Muoi N Hoang,
Natalie J Ayoub,
Natalie J Reese,
Naveen B Walker,
Ngoc B Kelsch,
Ngoc T Le,
Nianna C Burns,
Nicole Yuen,
Nympha V Florendo,
Patricia F Alberico,
Phal K Chhun,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Raphelia Spisso,
Richard W Tubb,
Robert C Hoover,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Romero,
Ronald P Boyce,
Rumany C Penn, PharmD,
Ryan J Borges,
Saied A Asbagh,
Sara Jdent Acosta,
Savannah E Samp,
Scott J Matsuda,
Scott N Lim,
Sean P Desbrow,
Shaquenta Y Perkins,
Sonia R Peterson,
Sparky L Bartee,
Stacie A Woods,
Steven J Branch,
Steven M Galvez,
Sundy V Sedwick,
Sydney S Taylor,
Taichun Qin, PhD,
Tammy Vasquez Hancock,
Tanya E Malais,
Tara L Stockton,
Thomas W Gordon,
Timothy C Grome,
Timothy P Lafave,
Trushani T Desai,
Uttaniti Limchumroon (Tom),
Vanessa R Muller,
Ve T Vuong,
Victoria L Morgan,
Virgilio F Pacio, CSO,
Wayne L Jefferson,
Wen Jun Peng,
Wendy S Antonowsky,
William J Leonard,
William J Weis,
Yolanda D Mitchell Lee,
Yvette Mlacour Davis,
Yvonne T Lacour,
Zachary A Bogorad,
Zachary Ryan Harris
Yen Tso Kuo's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2024 | FDA 483 | Avatar Foods Inc - Form 483, 2024-04-29 |
May, 2022 | FDA 483 | Grimmway Enterprises, Inc. dba Grimmway Farms - Form 483, 2022-05-04 |
October, 2023 | FDA 483 | Sol-ti Inc. - Form 483, 2023-10-05 |
July, 2023 | FDA 483 | Cali Rice Valley, Inc. - Form 483, 2023-07-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more